BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31699650)

  • 1. Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1
    Brown M; Turgeon C; Rinaldo P; Roullet JB; Gibson KM
    Mol Genet Metab; 2019 Dec; 128(4):397-408. PubMed ID: 31699650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal glutamine supplementation in murine succinic semialdehyde dehydrogenase deficiency, a disorder of γ-aminobutyric acid metabolism.
    Brown MN; Walters DC; Schmidt MA; Hill J; McConnell A; Jansen EEW; Salomons GS; Arning E; Bottiglieri T; Gibson KM; Roullet JB
    J Inherit Metab Dis; 2019 Sep; 42(5):1030-1039. PubMed ID: 31032972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.
    Malaspina P; Roullet JB; Pearl PL; Ainslie GR; Vogel KR; Gibson KM
    Neurochem Int; 2016 Oct; 99():72-84. PubMed ID: 27311541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic relevance of mTOR inhibition in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
    Vogel KR; Ainslie GR; Jansen EE; Salomons GS; Gibson KM
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):33-42. PubMed ID: 27760377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes.
    Kirby T; Walters DC; Brown M; Jansen E; Salomons GS; Turgeon C; Rinaldo P; Arning E; Ashcraft P; Bottiglieri T; Roullet JB; Gibson KM
    Metab Brain Dis; 2020 Apr; 35(4):601-614. PubMed ID: 32172518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rett syndrome (MECP2) and succinic semialdehyde dehydrogenase (ALDH5A1) deficiency in a developmentally delayed female.
    Brown M; Ashcraft P; Arning E; Bottiglieri T; McClintock W; Giancola F; Lieberman D; Hauser NS; Miller R; Roullet JB; Pearl P; Gibson KM
    Mol Genet Genomic Med; 2019 May; 7(5):e629. PubMed ID: 30829465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site.
    Leo S; Capo C; Ciminelli BM; Iacovelli F; Menduti G; Funghini S; Donati MA; Falconi M; Rossi L; Malaspina P
    Metab Brain Dis; 2017 Oct; 32(5):1383-1388. PubMed ID: 28664505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Missense Variant in
    Vernau KM; Struys E; Letko A; Woolard KD; Aguilar M; Brown EA; Cissell DD; Dickinson PJ; Shelton GD; Broome MR; Gibson KM; Pearl PL; König F; Van Winkle TJ; O'Brien D; Roos B; Matiasek K; Jagannathan V; Drögemüller C; Mansour TA; Brown CT; Bannasch DL
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategies.
    Vogel KR; Ainslie GR; Walters DC; McConnell A; Dhamne SC; Rotenberg A; Roullet JB; Gibson KM
    J Inherit Metab Dis; 2018 Jul; 41(4):699-708. PubMed ID: 29460030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity.
    Lee HHC; Pearl PL; Rotenberg A
    J Child Neurol; 2021 Nov; 36(13-14):1200-1209. PubMed ID: 33624531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
    Jansen EE; Vogel KR; Salomons GS; Pearl PL; Roullet JB; Gibson KM
    J Inherit Metab Dis; 2016 Nov; 39(6):795-800. PubMed ID: 27686230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.
    Knerr I; Pearl PL; Bottiglieri T; Snead OC; Jakobs C; Gibson KM
    J Inherit Metab Dis; 2007 Jun; 30(3):279-94. PubMed ID: 17457693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency.
    Kirby T; Walters DC; Shi X; Turgeon C; Rinaldo P; Arning E; Ashcraft P; Bottiglieri T; DiBacco M; Pearl PL; Roullet JB; Gibson KM
    Orphanet J Rare Dis; 2020 Sep; 15(1):261. PubMed ID: 32967698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succinic semialdehyde dehydrogenase deficiency: The combination of a novel ALDH5A1 gene mutation and a missense SNP strongly affects SSADH enzyme activity and stability.
    Menduti G; Biamino E; Vittorini R; Vesco S; Puccinelli MP; Porta F; Capo C; Leo S; Ciminelli BM; Iacovelli F; Spada M; Falconi M; Malaspina P; Rossi L
    Mol Genet Metab; 2018 Jul; 124(3):210-215. PubMed ID: 29895405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical diagnosis and mutation analysis of four Chinese families with succinic semialdehyde dehydrogenase deficiency.
    Wang P; Cai F; Cao L; Wang Y; Zou Q; Zhao P; Wang C; Zhang Y; Cai C; Shu J
    BMC Med Genet; 2019 May; 20(1):88. PubMed ID: 31117962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.
    Vogel KR; Ainslie GR; Gibson KM
    J Inherit Metab Dis; 2016 Nov; 39(6):877-886. PubMed ID: 27518770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine.
    Lee HHC; McGinty GE; Pearl PL; Rotenberg A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of thirty-four suspected pathogenic missense variants in ALDH5A1 gene associated with succinic semialdehyde dehydrogenase deficiency.
    Pop A; Smith DEC; Kirby T; Walters D; Gibson KM; Mahmoudi S; van Dooren SJM; Kanhai WA; Fernandez-Ojeda MR; Wever EJM; Koster J; Waterham HR; Grob B; Roos B; Wamelink MMC; Chen J; Natesan S; Salomons GS
    Mol Genet Metab; 2020 Jul; 130(3):172-178. PubMed ID: 32402538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.
    Jansen EE; Struys E; Jakobs C; Hager E; Snead OC; Gibson KM
    BMC Dev Biol; 2008 Nov; 8():112. PubMed ID: 19040727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency.
    Brown M; Ashcraft P; Arning E; Bottiglieri T; Roullet JB; Gibson KM
    Mol Genet Metab; 2019; 128(1-2):109-112. PubMed ID: 31345667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.